Hikma Pharmaceutical reported 1.96B in Current Assets for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
AstraZeneca AZN:LN 26.69B 583M
Bayer BAYN:GR 31.94B 506M
Fresenius FRE:GR € 17334M 433M
Fresenius Medical Care FMS:US $ 7999M 184.32M
Galapagos GLPG:NA 5.02B 113.5M
Genmab GEN:DC 21.95B 1.65B
GlaxoSmithKline GSK:LN 18.25B 688M
GRIFOLS GRF:SM € 3239.5M 153.93M
H. Lundbeck A/S LUN:DC 9.13B 987M
Hikma Pharmaceutical HIK:LN 1.96B 33M
Lonza Group LONN:SW 5.03B 229M
Merck MRK:GR € 10315M 133M
Orion ORNBV:FH 602.7M 13.3M
Recordati REC:IM 958.12M 50.73M